When no news is not good news: Shingrix Vaccination
Recently, Multiple Sclerosis New Zealand (MSNZ) wrote to Pharmac to express our immense disappointment with their Health Technologies Assessment (HTA) process, the treatment funding assessment process, and the impact this is having on the MS community. The varicella zoster virus, more commonly known as Shingles, is a viral infection which causes a painful rash and […]